Zacks Investment Research
03 Nov 2026, 19:40 UTC · 1h ago
Healthpeak's Q3 FFOA Beat Estimates on Leasing, Senior Housing Growth
Impact · against what's priced in
Healthpeak's Q3 results are marginally positive as lab occupancy trends toward recovery, a factor the market had previously discounted. However, the beat on FFOA and revenue is largely offset by the fact that these growth drivers, specifically Janus Living and medical leasing, are already baked into the current valuation.
- DOC+0.20
Challenges what's priced in
- The price assumes
A full recovery in the lab segment, which the price treats as permanently impaired
The market isn't paying for a lab recovery, but total lab occupancy improved to 79.8% (up 130 bps sequentially) with an additional 643,000 square feet under LOI, supporting a trend toward the stabilization the price currently discounts.
What DOC's price assumes · Sep 6
Top 1 mover · tap to explore
